Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 18 Jul 2022

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

in Hematologic Malignancies

Fortunato Morabito
Elena Zamagni
Concetta Conticello
Vincenzo Pavone
Salvatore Palmieri
Sara Bringhen
Monica Galli
Silvia Mangiacavalli
Daniele Derudas
Elena Rossi

Frontiers in Oncology

doi 10.3389/fonc.2022.890376

4,598 views
4 citations

Case Report

Published on 18 Jul 2022

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

in Hematologic Malignancies

Francesca Farina
V. Ferla
S. Marktel
D. Clerici
S. Mastaglio
T. Perini
C. Oltolini
R. Greco
F. Aletti
A. Assanelli

Frontiers in Oncology

doi 10.3389/fonc.2022.867301

4,449 views
3 citations

Review

Published on 18 Jul 2022

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

in Hematologic Malignancies

Massimo Bernardi
Felicetto Ferrara
Matteo Giovanni Carrabba
Sara Mastaglio
Francesca Lorentino
Luca Vago
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2022.890871

9,553 views
7 citations

Case Report

Published on 18 Jul 2022

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study

in Hematologic Malignancies

Yuxin Wang
Yao Sun
Jing Xie
Jiangwei Hu
Na Liu
Jianlin Chen
Botao Li
Sanchun Lan
Jingwen Niu
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.928324

3,597 views
4 citations

Original Research

Published on 15 Jul 2022

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment

in Hematologic Malignancies

Dao-Xing Deng
Shuang Fan
Xiao-Hui Zhang
Lan-Ping Xu
Yu Wang
Chen-Hua Yan
Huan Chen
Yu-Hong Chen
Wei Han
Feng-Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.916442

3,589 views
4 citations

Original Research

Published on 15 Jul 2022

Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data

in Hematologic Malignancies

Hailong Yuan
Gang Chen
Jianli Xu
Ruixue Yang
Maria Muhashi
Gulibadanmu Aizezi
Ming Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.913802

3,240 views
11 citations

Brief Research Report

Published on 14 Jul 2022

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

in Hematologic Malignancies

Yanglan Fang
Man Wang
Shuhong Hu
Tanzhen Wang
Yujie Liu
Jinyan Xiao
Yiming Cai
Ying Wang
Huiying Qiu
Xiaowen Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.896858

4,266 views
4 citations

Case Report

Published on 14 Jul 2022

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review

in Hematologic Malignancies

Hongbin Yu
Du He
Qing Zhang
Bei Cao
Weiping Liu
Yu Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.914379

6,936 views
9 citations

Original Research

Published on 14 Jul 2022

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

in Hematologic Malignancies

Claudia Vener
Silvia Rossi
Pamela Minicozzi
Rafael Marcos-Gragera
Hélène A. Poirel
Marc Maynadié
Xavier Troussard
Gabriella Pravettoni
Roberta De Angelis
Milena Sant

Frontiers in Oncology

doi 10.3389/fonc.2022.892684

7,014 views
5 citations

Review

Published on 14 Jul 2022

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges

in Hematologic Malignancies

Romanos Sklavenitis-Pistofidis
Gad Getz
Irene Ghobrial
Maria Papaioannou

Frontiers in Oncology

doi 10.3389/fonc.2022.961421

4,512 views
3 citations

Review

Published on 14 Jul 2022

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

in Hematologic Malignancies

Yujie Zhang
Zhichao Xing
Li Mi
Zhihui Li
Jingqiang Zhu
Tao Wei
Wenshuang Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.929012

10,220 views
13 citations

Original Research

Published on 14 Jul 2022

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

in Hematologic Malignancies

Tingting Cheng
Yan Chen
Yi Liu
Xia Ma
Cong Zeng
Xu Chen
Shiyu Wang
Yajing Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.922120

3,379 views
5 citations

Review

Published on 13 Jul 2022

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies

in Hematologic Malignancies

Fengli Zuo
Jing Yu
Xiujing He

Frontiers in Oncology

doi 10.3389/fonc.2022.931393

7,936 views
11 citations

Original Research

Published on 13 Jul 2022

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study

in Hematologic Malignancies

Shuo Liu
Weiping Liu
Huichao Li
Lei Yang
Yuqin Song
Xi Zhang
Yangyang Cheng
Qingyu Li
Haoxin Li
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.863269

9,360 views
12 citations

Original Research

Published on 12 Jul 2022

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Matthew Kaufman
Xiao-Jie Yan
Wentian Li
Emanuela M. Ghia
Anton W. Langerak
Laura Z. Rassenti
Chrysoula Belessi
Neil E. Kay
Frederic Davi
John C. Byrd

Frontiers in Oncology

doi 10.3389/fonc.2022.897280

8,255 views
3 citations

Review

Published on 12 Jul 2022

Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia

in Hematologic Malignancies

Steven A. Manobianco
Tara Rakiewicz
Lindsay Wilde
Neil D. Palmisiano

Frontiers in Oncology

doi 10.3389/fonc.2022.892289

5,426 views
7 citations

Original Research

Published on 11 Jul 2022

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study

in Hematologic Malignancies

Jingjing Ma
Zhiguang Lin
Tianling Ding
Qing Li
Mengxue Zhang
Hui Kang
Patrick B. Johnston
Yan Ma
Bobin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.938421

3,481 views
6 citations

Original Research

Published on 11 Jul 2022

Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation

in Hematologic Malignancies

Hong Wang
Jiaqian Qi
Xueqian Li
Tiantian Chu
Huiying Qiu
Chengcheng Fu
Xiaowen Tang
Changgeng Ruan
Depei Wu
Yue Han

Frontiers in Oncology

doi 10.3389/fonc.2022.940320

3,171 views
8 citations

Case Report

Published on 08 Jul 2022

Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis Systemic Infection in Patients Treated for Leukemia, an Emergency Not to Be Missed

in Hematologic Malignancies

Manon Delafoy
Juliette Goutines
Aude-Marie Fourmont
André Birgy
Maryline Chomton
Michaël Levy
Jérôme Naudin
Lara Zafrani
Lou Le Mouel
Karima Yakouben

Frontiers in Oncology

doi 10.3389/fonc.2022.912695

3,516 views
6 citations

Brief Research Report

Published on 08 Jul 2022

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Giulia Veltri
Federica Lovisa
Giuliana Cortese
Marta Pillon
Elisa Carraro
Simone Cesaro
Massimo Provenzi
Salvatore Buffardi
Samuela Francescato
Alessandra Biffi

Frontiers in Oncology

doi 10.3389/fonc.2022.913487

3,529 views
5 citations

Brief Research Report

Published on 08 Jul 2022

Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic Progression

in Hematologic Malignancies

Sarah Sandmann
Yvonne Lisa Behrens
Claudia Davenport
Felicitas Thol
Michael Heuser
Daniela Dörfel
Friederike Löhr
Agnes Castrup
Doris Steinemann
Julian Varghese

Frontiers in Oncology

doi 10.3389/fonc.2022.888114

3,545 views
2 citations

Original Research

Published on 07 Jul 2022

Characteristics, Treatment Complexity, and Outcome of Mixed-Phenotype Acute Leukemia in Children in a Low–Middle-Income Country

in Hematologic Malignancies

Maram Salama
Sonia Ahmed
Sonya Soliman
Nahla El-Sharkawy
Sherine Salem
Amr El-Nashar
Reham Khedr
Leslie Lehmann
Iman Sidhom
Alaa El-Haddad

Frontiers in Oncology

doi 10.3389/fonc.2022.941885

5,947 views
2 citations

Review

Published on 07 Jul 2022

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

in Hematologic Malignancies

Yutong Xie
Huan Yang
Chao Yang
Liren He
Xi Zhang
Li Peng
Hongbin Zhu
Lei Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.933666

6,380 views
20 citations

Original Research

Published on 07 Jul 2022

FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML

in Hematologic Malignancies

Jubin Zhang
Lijuan Qi
Tanzhen Wang
Jingnan An
Biqi Zhou
Yanglan Fang
Yujie Liu
Meng Shan
Dengli Hong
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.890346

3,991 views
7 citations

2,059 articles

articles

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment

Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study

Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation

Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis Systemic Infection in Patients Treated for Leukemia, an Emergency Not to Be Missed

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia

Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic Progression

Characteristics, Treatment Complexity, and Outcome of Mixed-Phenotype Acute Leukemia in Children in a Low–Middle-Income Country

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML